Skip to main content

Diabetes Mellitus News (Page 4)

Mounjaro, Zepbound Cut Odds for Diabetes by 94% in At-Risk People, Study Finds

TUESDAY, Aug. 20, 2024 – Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes...

Mounjaro, Zepbound Cut Odds for Diabetes by 94% in At-Risk People, Study Finds

TUESDAY, Aug. 20, 2024 – Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes...

Automated Multiorgan CT Can Predict Diabetes, Other Conditions

FRIDAY, Aug. 16, 2024 – Automated multiorgan computed tomography (CT), including visceral fat, can predict diabetes and associated cardiometabolic conditions, according to a study published online...

Diabetes Run in Your Family? Diet, Exercise Can Still Prevent It

FRIDAY, Aug. 9, 2024 – Folks can overcome their genetic risk for type 2 diabetes through healthy diet and regular exercise, a new study says. A healthy lifestyle reduced the risk of type 2 diabetes...

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

FRIDAY, July 26, 2024 – Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings. "Abbott has recently...

Too Little, Too Much: Poor Sleep Linked to Vessel Damage in Those With Diabetes

MONDAY, July 15, 2024 – Diabetics who sleep too little or too much are more likely to suffer damage to their small blood vessels, a condition that can cause organ damage throughout their bodies....

Facial Temperatures Might Help Docs Diagnose Diabetes, Fatty Liver Disease

WEDNESDAY, July 3, 2024 – Screening for chronic illnesses like diabetes or fatty liver disease could one day be as simple as checking the temperature of your nose, eyes or cheeks. The temperature of...

Men Are More Debilitated by Diabetes Than Women

FRIDAY, May 17, 2024 – Men are more vulnerable than women to the debilitating effects of diabetes, a new long-term study finds. Overall rates of diabetes are similar between men and women, according...

Global Life Expectancy Could Rise By More Than 4 Years by 2050

FRIDAY, May 17, 2024 – Life expectancy around the world is expected to increase by nearly 5 years in men and more than 4 years in women during the next three decades, researchers predict. These...

More Than 200 Insulin Pump Users Injured After App Causes Malfunction

THURSDAY, May 9, 2024 – The U.S. Food and Drug Administration has issued a Class 1 recall – its most urgent kind – for an IOS app linked to a specific kind of insulin pump used by people with...

Diabetes Increases Risk for Functional Limitations in Older Adults

FRIDAY, May 3, 2024 – Older adults with diabetes are more likely to develop functional limitations than adults without diabetes, according to a study published online April 16 in the Canadian...

FDA Approves Zituvio (sitagliptin) for the Treatment of Adult Patients with Type 2 Diabetes Mellitus

AHMEDABAD, India, Oct. 20, 2023 /PRNewswire/ – Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug...

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

July 24, 2019 – The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be...

Baxter Announces U.S FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion

DEERFIELD, Ill. - July 22, 2019 Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA)...

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

 3 May 2019 – The US Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetes, Type 2, Diabetic Neuropathy, Diabetic Nerve Damage, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes

Related drug support groups

Tresiba, Levemir, insulin degludec